Home RxNorm 2398131 olatuzumab vedotin-piiq 30 MG Injection Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2398131
RxNorm name olatuzumab vedotin-piiq 30 MG Injection
Display name olatuzumab vedotin-piiq 30 MG Injection
Full name olatuzumab vedotin-piiq 30 MG Injection
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:38:50 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761121 Polivy polatuzumab vedotin-piiq 351(a) Rx 2026-08-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 20a16ab2-f338-4abb-9dcd-254bd949a2bc olatuzumab vedotin-piiq 30 MG Injection [PSN] · polatuzumab vedotin-piiq 30 MG Injection [SCD] 2 14 These highlights do not include all the information needed to use POLIVY safely and effectively. See full prescribing information for POLIVY. POLIVY ® (polatuzumab vedotin-piiq) for injection, for intravenous use Initial U.S. Approval: 2019 20260324